Rome, Italy

Guido Rasi

USPTO Granted Patents = 3 



Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012-2015

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Guido Rasi

Introduction

Guido Rasi is a prominent inventor based in Rome, Italy, known for his significant contributions to the field of immunology. With a total of three patents to his name, Rasi has focused on developing innovative solutions for cancer treatment and immune system enhancement.

Latest Patents

Rasi's latest patents include groundbreaking inventions such as anti-tumoral immunogenic peptides and vaccines. This invention relates to novel, Frizzled-like, immunogenic peptides that are useful for stimulating an immune response against various cancer types, particularly colon rectal carcinoma. Another notable patent is a method for treating humans infected with specific pathogens by using thymosin alpha 1 as an immuno-stimulator to activate dendritic cells. This method is particularly beneficial in preventing infections in immuno-compromised hosts undergoing bone marrow transplantation.

Career Highlights

Throughout his career, Rasi has worked with various organizations, including Sciclone Pharmaceuticals, Inc. His work has significantly impacted the development of immunotherapeutic strategies aimed at enhancing the immune response against cancer and infections.

Collaborations

Rasi has collaborated with notable colleagues in the field, including Enrico Garaci and Francesco Bistoni. These collaborations have further enriched his research and innovations.

Conclusion

Guido Rasi's contributions to immunology through his patents and collaborations highlight his commitment to advancing medical science. His innovative approaches to cancer treatment and immune system enhancement continue to inspire future research and development in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…